Regeneron Pharmaceuticals Inc. (REGN)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Roberts Officer	$182.44	521	$95,051.24	1,200	2012-11-30	Filing
Roberts Officer	$181.47	1,515	$274,927.05	1,721	2012-11-30	Filing
Roberts Officer	$180.67	5,010	$905,156.70	3,236	2012-11-30	Filing
Roberts Officer	$179.43	2,600	$466,518.00	8,246	2012-11-30	Filing
Roberts Officer	$178.27	430	$76,656.10	10,846	2012-11-30	Filing
Roberts Officer	$177.43	224	$39,744.32	11,276	2012-11-30	Filing
Aberman Officer	$184.00	100	$18,400.00	10,500	2012-11-30	Filing
Aberman Officer	$183.77	200	$36,754.00	10,600	2012-11-30	Filing
Aberman Officer	$182.39	200	$36,478.00	10,800	2012-11-30	Filing
Aberman Officer	$181.59	400	$72,636.00	11,000	2012-11-30	Filing
Aberman Officer	$180.08	3,004	$540,960.32	11,400	2012-11-30	Filing
Stahl Officer	$181.01	17,182	$3,110,113.82	41,939	2012-11-30	Filing
Vagelos Officer, Director	$181.19	17,155	$3,108,314.45	56,946	2012-11-29	Filing
Vagelos Officer, Director	$180.59	12,000	$2,167,080.00	74,101	2012-11-29	Filing
Vagelos Officer, Director	$179.60	19,733	$3,544,046.80	86,101	2012-11-29	Filing
Vagelos Officer, Director	$178.71	18,440	$3,295,412.40	105,834	2012-11-29	Filing
Vagelos Officer, Director	$177.09	4,402	$779,550.18	124,274	2012-11-29	Filing
Vagelos Officer, Director	$176.54	5,100	$900,354.00	128,676	2012-11-29	Filing
Vagelos Officer, Director	$175.95	1,800	$316,710.00	133,776	2012-11-29	Filing
Vagelos Officer, Director	$175.03	7,004	$1,225,910.12	135,576	2012-11-28	Filing